Managing menopause: weighing up the evidence 2017-19


Managing menopause: weighing up the evidence 2017-19

This Active Learning Module (ALM) has been developed to improve health professionals' knowledge and understanding of menopausal treatment options.

It covers the following points:

  • Signs and symptoms of menopause
  • Benefits and risks of treatment options (HRT/MHT, complementary therapies, non-hormonal treatment options)

The activity seeks to assist health professionals to provide well-informed, up-to-date advice and treatment in the care and management of menopausal women. 

Duration and general information

6 hours

The entire ALM does not need to be completed in one sitting; participants can stop once an activity has been completed and start the next activity at a later date.Once activities are completed and submitted, they can be reviewed but not edited. You can print your submitted answers and the recommended responses (where applicable) by revisiting the activities.

These ALMs have been designed to be completed on a laptop, desktop or tablet (not phones).

Assessment

Jean Hailes for Women's Health is an accredited provider of high-quality continuing professional development activities for health professionals. 

The content of each completed ALM will be assessed internally by Jean Hailes' RACGP QI&CPD accredited Education Activity Representatives. Participants may be asked to repeat and re-submit activities if they are do not meet the expected requirements.

RACGP QI&CPD points and certificates of completion will only be provided once submitted content meets the required standard. 

Structure and content

There are four components to the ALM which will take approximately 6 hours to complete: 

  • Pre-disposing activity (self-reflection)
  • Structured learning component (online and back at your practice activities) 
  • Reinforcing activity (self-reflection)
  • Evaluation questionnaire (essential to complete this to receive CPD points)

Learning outcomes:

At the conclusion of the ALM, participants will be able to:

  • Outline the latest research findings on appropriate menopause management options in diverse population groups and clinical indications
  • Implement an evidence-based risk assessment and detail a safe and effective management plan for women requiring hormone therapy
  • Provide a rationale for menopause treatment option/s
  • Identify appropriate educational resources for patients experiencing menopause

RACGP: This activity has been approved by the RACGP QI&CPD Program in the 2017-2019 triennium. 40 Category 1 points – approved for Women's Health. The activity number is 101467.

Download the RACGP feedback form.

ACRRM: This activity is accredited with 30 PRPD points and 30 Obstetrics and Gynaecology / Women's Health MOPS points. The activity code is 9746.

RANZCOG: Fellows of RANZCOG can claim 1 point per hour for educational activities under the RANZCOG CPD self-education category.

Assessment

Jean Hailes for Women's Health is an accredited provider of high-quality continuing professional development activities for health professionals. 

The content of each completed ALM will be assessed internally by Jean Hailes' RACGP QI&CPD accredited Education Activity Representatives. Participants may be asked to repeat and re-submit activities if they are do not meet the expected requirements.

RACGP QI&CPD points and certificates of completion will only be provided once submitted content meets the required standard.

The Australasian Menopause Society (AMS) provides a range of information for women and clinicians including a search function for an AMS doctor. Access their guide to equivalent HRT/MHT doses.

Davis SR, Worsley R, Bell RJ. Use of complementary and alternative medicines for menopausal symptoms in Australian women aged 40–65 years. Medical Journal of Australia 2015;203(3).

Faubion S, Kuhle CL, Shuster LT, Rocca WA. Long-term health consequences of premature or early menopause and considerations for management. Climacteric 2015;18(4):483-491.

Other references (not open access):

Davis SR, Lambrinoudaki I, Lumsden M, Mishra GD, Pal L, Rees M, Santoro N, Simoncini T. Menopause. Nature Reviews Disease Primers 2015;(Apr 23)1:1500-1504.

Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women's midlife health and menopause hormone therapy. Climacteric 2016;19(2):109-150.

Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Attitude of German gynecologists towards prescribing HRT before and after the WHI study. Climacteric 2012;15(4):326-331.

Velentzis LS, Banks E, Sitas F, Salagame U, Tan EH, Canfell K. Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study. PLoS One 2016;11(3).


Other Active Learning Modules

Diagnosis and management of PCOS 2017-19
Find out more  right arrow
6 hours, 40 RACGP QI&CPD points
Improve your knowledge and understanding of PCOS, its diagnosis and key management principles.
Fertility, infertility and preconception care 2017-19
Find out more  right arrow
This ALM provides an overview of fertility awareness and preconception care, the causes of infertility and indications for specialist referral.
Subscribe To our newsletters